Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin

Completed

• Conditions: Gastric Ulcer; Duodenal Ulcer
• Interventions: Other: No Intervention

• Registration Number: NCT02423187
• Lead Sponsor: Eisai Co., Ltd.

Brief Summary

To investigate the safety and efficacy of long-term combination therapy with rabeprazole and low-dose aspirin.

Detailed Description

Not available

Study Timeline

• Study Start: 2015-03-17
• Study First Submitted: 2015-04-17
• Study First Submitted QC: 2015-04-17
• Study First Posted: 2015-04-22
• Primary Completion: 2017-10-30
• Study Completion: 2017-10-30
• Status Verified: 2018-07
• Last Update Submitted: 2018-08-27
• Last Update Posted: 2018-08-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1568

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Arm 1	No Intervention	Participants with combination therapy (rabeprazole and low-dose aspirin)

Primary Outcome Measures

Name	Time	Method
Incidence of adverse drug reactions	52 weeks

Secondary Outcome Measures

Name	Time	Method
Recurrence rate of peptic ulcer	52 weeks